Kymera Therapeutics Ownership | Who Owns Kymera Therapeutics?
Kymera Therapeutics Ownership Summary
Kymera Therapeutics is owned by 90.59% institutional investors, 1.27% insiders, and 8.13% retail investors. Price t rowe associates inc /md/ is the largest institutional shareholder, holding 9.03% of KYMR shares. T. Rowe Price New Horizons is the top mutual fund, with 4.86% of its assets in Kymera Therapeutics shares.
KYMR Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Kymera Therapeutics | 90.59% | 1.27% | 8.13% |
| Sector | Healthcare Stocks | 49.73% | 8.84% | 41.43% |
| Industry | Biotech Stocks | 47.04% | 8.74% | 44.21% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Price t rowe associates inc /md/ | 6.39M | 9.03% | $190.76M |
| Baker bros. advisors lp | 6.00M | 8.47% | $178.98M |
| Atlas venture life science advisors | 5.35M | 7.56% | $159.71M |
| Bvf inc/il | 5.16M | 7.29% | $154.08M |
| Fmr | 4.83M | 6.82% | $144.08M |
| Vanguard group | 4.82M | 6.81% | $143.95M |
| Wellington management group llp | 4.31M | 6.09% | $128.64M |
| Blackrock | 4.16M | 5.87% | $124.04M |
| Avoro capital advisors | 3.89M | 5.50% | $116.08M |
| Artal group | 3.01M | 4.25% | $89.72M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Atlas venture life science advisors | 5.35M | 16.82% | $159.71M |
| Aquilo capital management | 328.74K | 9.46% | $9.81M |
| Bvf inc/il | 5.16M | 4.32% | $154.08M |
| Redmile group | 1.58M | 2.85% | $47.14M |
| Deer management | 415.89K | 2.55% | $12.41M |
| Artal group | 3.01M | 2.29% | $89.72M |
| Baker bros. advisors lp | 6.00M | 2.29% | $178.98M |
| Avoro capital advisors | 3.89M | 1.55% | $116.08M |
| Deep track capital, lp | 1.50M | 1.34% | $44.77M |
| Propel bio management | 56.36K | 1.09% | $1.68M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Blackrock | 4.16M | 0.00% | 499.77K |
| Fmr | 4.83M | 0.01% | 462.43K |
| Eventide asset management | 462.10K | 0.24% | 442.32K |
| Ubs asset management americas | 433.57K | 0.00% | 253.63K |
| Deep track capital, lp | 1.50M | 1.34% | 237.75K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| State street | 1.91M | 0.00% | -761.83K |
| Jpmorgan chase | 44.94K | 0.00% | -410.99K |
| Rock springs capital management lp | 1.16M | 1.05% | -358.26K |
| Barclays | 49.09K | 0.00% | -270.81K |
| Citigroup | 19.59K | 0.00% | -201.32K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Driehaus capital management | 223.41K | 0.06% | 223.41K | $6.67M |
| Norges bank | 117.88K | 0.00% | 117.88K | $3.52M |
| Capital fund management | 29.95K | 0.00% | 29.95K | $894.07K |
| Mirae asset global etfs | 24.57K | 0.00% | 24.57K | $734.68K |
| Corebridge financial | 23.93K | 0.00% | 23.93K | $714.34K |
Sold Out
| Holder | Change |
|---|---|
| Financial gravity asset management | -2.00 |
| Riggs asset managment | -7.00 |
| Nelson, van denburg & campbell wealth management group | -8.00 |
| Continuum advisory | -13.00 |
| Innealta capital | -44.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2024 | 181 | 16.03% | 68,964,551 | 2.37% | 90 | 1.00% | 93 | 6.90% | 62 | 31.91% |
| Jun 30, 2024 | 155 | -4.32% | 67,367,833 | 0.44% | 95 | 0.72% | 86 | -14.85% | 47 | 11.90% |
| Mar 31, 2024 | 162 | 20.00% | 67,073,034 | 11.04% | 114 | 1.07% | 101 | 48.53% | 42 | -17.65% |
| Dec 31, 2023 | 135 | 10.66% | 60,406,777 | 5.38% | 103 | 1.07% | 68 | 11.48% | 51 | 45.71% |
| Sep 30, 2023 | 122 | -6.87% | 57,323,132 | -1.85% | 98 | 0.98% | 61 | -8.96% | 35 | 6.06% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| T. Rowe Price New Horizons | 3.14M | 4.86% | -9.90K |
| US Small-Cap Growth II Equity Comp | 3.14M | 4.86% | 161.32K |
| Fidelity Growth Compy Commingled Pl S | 2.25M | 3.47% | 12.35K |
| Fidelity Growth Compy Commingled Pl O | 2.24M | 3.46% | 52.60K |
| Vanguard Health Care Inv | 1.83M | 2.82% | 378.94K |
| Fidelity Growth Company Fund | 1.65M | 2.55% | -3.50K |
| Vanguard Total Stock Mkt Idx Inv | 1.53M | 2.37% | -9.61K |
| Vanguard Small Cap Index | 1.21M | 1.87% | 2.35K |
| T. Rowe Price Health Sciences | 1.20M | 1.85% | -11.65K |
| iShares Russell 2000 ETF | 1.15M | 1.77% | -2.58K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Dec 02, 2024 | Esposito Pamela | - | Sell | $122.50K |
| Sep 17, 2024 | Esposito Pamela | - | Sell | $303.18K |
| Sep 17, 2024 | Esposito Pamela | - | Sell | $348.58K |
| Aug 26, 2024 | Albers Jeffrey W. | - | Sell | $245.51K |
| Aug 20, 2024 | BVF PARTNERS L P/IL | See Remarks and Footnotes | Buy | $15.67 |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2024 Q4 | - | 1 |
| 2024 Q3 | 5 | 16 |
| 2024 Q2 | - | 9 |
| 2024 Q1 | 3 | 49 |
| 2023 Q4 | 6 | - |
KYMR Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools